Global Heart Valve Devices Market – Industry Trends & Forecast to 2026

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44 208 089 1725

Global Heart Valve Devices Market – Industry Trends & Forecast to 2026

Global
Upcoming Reports
Global Heart Valve Devices Market
  • No of pages :
    350
  • No of Figures:
    60
  • No of Tables:
    220
  • Report Type:
    Upcoming
  • Category:

Global Heart Valve Devices Market By Usage (Heart Valve Repair, Heart Valve Replacement), Product Type (Mechanical Heart Valves, Trans-Catheter/Percutaneous Heart Valves, Tissue/Bio-Prosthetic Heart Valves), End-User (Hospitals, Ambulatory Surgical Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Heart Valve Devices Market

Global Heart Valve Devices Market is expected to rise from its initial estimated value of USD 6.45 billion in 2018 to a projected value of USD 15.41 billion by 2026, registering a CAGR of 11.50% in the forecast period of 2019-2026. This rise in market value can be attributed to growth in the levels of geriatric population and increasing prevalence of unhealthy lifestyle choices globally.

Market Definition: Global Heart Valve Devices Market

Heart valve devices can be termed as the heart valves that are used in the cardiovascular surgical procedures for the repair and replacement of worn out or damaged parts. These heart valves are used to keep the blood flowing throughout the body by pumping it and letting the blood flow in different directions.

Market Drivers:

  • Growing levels of innovations in technology resulting in advanced levels of product offerings has resulted in growth of demand for the product
  • Increasing incidences of heart diseases and cardiovascular disorders that have been a result of increase in obesity levels

Market Restraint:

  • Increasing levels of cost associated with the cardiovascular surgical procedure is expected to act as a restraint to the market growth

Segmentation: Global Heart Valve Devices Market

  • By Usage
    • Heart Valve Repair
      • Surgical Heart Valve Repair
      • Percutaneous Balloon Valvuloplasty
      • Transcatheter Heart Valve Repair
    • Heart Valve Replacement
  • By Product Type
    • Mechanical Heart Valves
      • Aortic Valves
      • Mitral Valves
    • Trans-Catheter/Percutaneous Heart Valves
      • Aortic Valves
      • Mitral Valves
      • Pulmonary Valves
    • Tissue/Bio-Prosthetic Heart Valves
      • Aortic Valves
      • Mitral Valves
      • Pulmonary Valves
      • Tricuspid Valves
  • By End-User
    • Hospitals
    • Ambulatory Surgical Centers
  • By Geography
    • North America
      • US.
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific
    • Middle East & Africa
      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Key Developments in the Market:

  • In December 2018, Meril Life Sciences Pvt. Ltd. announced the launch of artificially manufactured aortic heart valves for patients reluctant to undergo open heart valve replacement surgery. The “Trans-Catheter Aortic Heart Valve Replacement (TAVR)” will be sold under the name of “Myval”.
  • In January 2018, LivaNova PLC announced that they had initiated the “BELIEVE” (Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant) study. The study is initiated to identify the incidences of leaflet motion through CT imaging for the patients using LivaNova bioprosthetic aortic heart valve.
  • In January 2017, Abbott announced that they had completed the acquisition of St. Jude Medical, Inc. This acquisition will help in establishing Abbott as a major leader for the provision of medical devices and expanding their product portfolios significantly.

Competitive Analysis: Global Heart Valve Devices Market

Global heart valve devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of heart valve devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Heart Valve Devices Market

Major competitors currently present in the market are Abbott; CryoLife; Micro Interventional Devices, Inc.; Boston Scientific Corporation; LivaNova PLC; Meril Life Sciences Pvt. Ltd.; Edwards Lifesciences Corporation; Medtronic; Auto Tissue Berlin GmbH; lepumedical.com; Neovasc Inc.; TTK HealthCare and JenaValve Technology, Inc.

Research Methodology: Global Heart Valve Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global heart valve devices market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Choose Licence Type

Enterprise, Single User

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figures

Please fill in the below form and our sales representatives will get back to you Shortly

Please fill in the below form and our sales representatives will get back to you Shortly

`